ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 135 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 2.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $25,000 | -10.7% | 17,395 | -12.3% | 0.00% | – |
Q4 2016 | $28,000 | -73.1% | 19,832 | -66.5% | 0.00% | -100.0% |
Q3 2016 | $104,000 | -21.8% | 59,202 | -23.8% | 0.00% | 0.0% |
Q2 2016 | $133,000 | -13.6% | 77,739 | -0.6% | 0.00% | 0.0% |
Q1 2016 | $154,000 | +32.8% | 78,233 | +27.7% | 0.00% | 0.0% |
Q4 2015 | $116,000 | +5.5% | 61,278 | +6.1% | 0.00% | 0.0% |
Q3 2015 | $110,000 | -52.6% | 57,767 | +15.6% | 0.00% | -50.0% |
Q2 2015 | $232,000 | +6.9% | 49,980 | +0.5% | 0.00% | 0.0% |
Q1 2015 | $217,000 | +26.9% | 49,748 | +0.8% | 0.00% | 0.0% |
Q4 2014 | $171,000 | -16.6% | 49,329 | +0.7% | 0.00% | -33.3% |
Q3 2014 | $205,000 | -28.1% | 48,980 | +0.6% | 0.00% | -25.0% |
Q2 2014 | $285,000 | -10.7% | 48,670 | -3.8% | 0.00% | 0.0% |
Q1 2014 | $319,000 | +13.1% | 50,567 | +4.9% | 0.00% | 0.0% |
Q4 2013 | $282,000 | +8.5% | 48,206 | -2.3% | 0.00% | -20.0% |
Q3 2013 | $260,000 | -34.2% | 49,335 | -3.8% | 0.01% | -44.4% |
Q2 2013 | $395,000 | – | 51,309 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANGROVE PARTNERS IM, LLC | 1,281,400 | $6,753,000 | 3.37% |
Perceptive Advisors | 5,116,200 | $26,962,000 | 1.11% |
SAMLYN CAPITAL, LLC | 2,266,565 | $11,945,000 | 0.33% |
Tradeworx Inc. | 132,839 | $700,000 | 0.32% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,216,579 | $6,411,000 | 0.30% |
Lyons Wealth Management, LLC. | 56,775 | $299,000 | 0.27% |
DIALECTIC CAPITAL MANAGEMENT, LP | 125,000 | $659,000 | 0.15% |
Schonfeld Group Holdings LLC | 11,400 | $60,000 | 0.12% |
DIALECTIC CAPITAL MANAGEMENT, LP | 70,000 | $369,000 | 0.08% |
ELLINGTON MANAGEMENT GROUP LLC | 72,000 | $379,000 | 0.07% |